Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort studyCarla Casulo, Matthew J. Maurer, Melissa C. Larson et al.|The Lancet Haematology|2022Cited by 65
Human immune organoids to decode B cell response in healthy donors and patients with lymphomaZhong Zhe, Ankur Singh, Rafick‐Pierre Sékaly et al.|Nature Materials|2024Cited by 59
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphomaJuan Pablo Alderuccio, Izidore S. Lossos, Isildinha M. Reis et al.|Blood|2023Cited by 14
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method surveyR. Andrew Harkins, Christopher R. Flowers, Sharvil Patel et al.|Blood Advances|2022Cited by 11
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐<scp>GemOx</scp>: A Multicenter Cohort StudySamuel Yamshon, Loretta J. Nastoupil, Jean L. Koff et al.|American Journal of Hematology|2025Cited by 10